CAHR Abstracts 2006
HOME
MAIN MENU
Search CAHR Abstracts
CLINICAL SCIENCES: POSTER PRESENTATIONS
229 - IMPROVEMENT IN LIPOATROPHY AND LIPID ABNORMALITIES FOLLOWING SWITCH FROM STAVUDINE (D4T) TO TENOFOVIR...
230 - TENOFOVIR DF (TDF) IN COMBINATION WITH LAMIVUDINE (3TC) AND EFAVIRENZ (EFV) IN ANTIRETROVIRAL-NAÏVE ...
231 - STUDY OF ANTIBACTERIAL ACTIVITY OF LOCAL MEDICINAL PLANTS FOR TREATMENT OF DIARRHEA IN HIV/AIDS PATIENTS...
232 - SAFETY AND EFFICACY OF ANTIRETROVIRAL TREATMENT (ART) REGIMENS CONTAINING TENOFOVIR DF (TDF) AND ATA...
233 - TENOFOVIR, NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) AND OTHER CUMULATIVE FACTORS ASSOCIATED WITH...
234 - RENAL SAFETY PROFILE IN HAART REGIMENS CONTAINING TENOFOVIR DF
235 - RARE SELECTION OF K65R IN HIV-PATIENTS FAILING A TENOFOVIR CONTAINING REGIMEN
236 - RARE OCCURRENCE OF RENAL IMPAIRMENT WHEN RETROSPECTIVELY EVALUATING THE USE OF TENOFOVIR DF WHEN USED...
237 - UNDERSTANDING THE OBSTACLES TO LIVER TRANSPLANTATION IN HIV-INFECTED CANADIANS
238 - CHANGE IN ENDOGENOUS INTERFERON LEVELS WITH HAART MAY PREDICT LIVER TOXICITY IN HIV-HCV CO-INFECTION
239 - HIGH RISK OF UNRECOGNIZED ADRENAL SUPPRESSION AND SYMPTOMS OF STEROID EXCESS IN HIV+ CLINIC PATIENTS...
240 - APOLIPOPROTEINS AND CAROTID ARTERY THICKENING IN THE CANADIAN HIV VASCULAR STUDY COHORT
241 - LONGITUDINAL STUDY OF VASCULAR MARKERS OF PREMATURE ATHEROSCLEROSIS AND METABOLIC CORRELATES IN HIV...
242 - EFFECTS OF NRTI-SPARING AND NRTI-CONTAINING REGIMENS ON MITOCHONDRIAL/NUCLEAR (MT/N) DNA RATIOS
243 - LEUKAPHERESIS: A POWERFUL TOOL FOR COLLECTION OF PERIPHERAL BLOOD MONONUCLEAR CELLS FROM HIV INFECTED...
244 - DENTAL CARE IN HIV+ PATIENTS: A NECESSITY, NOT AN OPTION
245 - AUDITORY SYPHILIS In PERSONS WITH HIV COINFECTION
246 - CLINICAL EXPERIENCE IN USING ABACAVIR + LAMIVUDINE + ZIDOVUDINE (TRIZIVIR) FOR INITIAL THERAPY AND FOR...
247 - THE IMPACT OF UNSTRUCTURED TREATMENT INTERRUPTIONS DURING MAINTENANCE THERAPY
248 - PREVALENCE AND IMPACT OF PRIMARY RESISTANCE IN DRUG NAÏVE INJECTION DRUG USERS (IDUs)
249 - ADEQUACY OF HIV TESTING AND FOLLOW-UP OF INFANTS BORN TO HIV-INFECTED MOTHERS IN ONTARIO
250 - UNDERUTILIZATION OF NUTRITIONAL RESOURCES BY HIV-INFECTED PATIENTS FOLLOWED AT A REGIONAL HIV CENTRE
251 - TRENDS IN ANTIRETROVIRAL RESISTANCE AMONG PERSONS DYING OF HIV-RELATED CAUSES IN BRITISH COLUMBIA...
252 - QUALITY OF LIFE WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION AND ASSOCIATED HEALTH STATES
253 - A COMPARISON OF REPORTING OF ADVERSE DRUG EVENTS (ADEs) IN QUESTIONNAIRES TO EVENTS RECORDED BY CHAR
254 - "2+1": A CLINICAL AND MANAGERIAL LOOK AT A PROGRAM FOR ARV-ADHERENT PATIENTS
255 - CLINICAL, DEMOGRAPHIC, AND HEALTH RESOURCE UTILIZATION CHARACTERISTICS OF HIV-INFECTED SUB-SAHARAN...
256 - EVALUATING THE COST AND CHARACTERISTICS OF ANTIRETROVIRAL WASTAGE IN A REGIONAL HIV/AIDS CARE PROGAM
257 - A COMPARISON OF ADMINISTRATIVE AND CLINICAL DATA FOR HIV OBSERVATIONAL DATABASE RESEARCH IN ONTARIO
258 - A SNAPSHOT FROM THE QASI INTERNATIONAL EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR CD4 T-CELL ENUMERA...
259 - COMPARISON OF VIRAL LOAD TESTING AT LOCAL AND CENTRAL LABORATORIES
260 - PREDICTION OF HIV-1 DRUG SUSCEPTIBILITY PHENOTYPE FROM VIRAL GENOTYPE USING LINEAR REGRESSION MODELING
261 - A NOVEL QUANTITATIVE HIV-1 P24 CAPTURE BEAD-ASSAY